For adults with type 2 diabetes and established atherosclerotic cardiovascular disease, high cardiovascular risk, chronic kidney disease, or heart failure, guidelines recommend GLP-1 agonists with proven cardiovascular benefit as preferred agents, independent of metformin use or baseline A1C
So the delivery of GPx3 to breast tumor tissues through hiPSC-MSCs or other methods may promote its expression, and reduce the influence of ROS on the progression of breast cancer accordingly, finally achieve the goal of treating breast cancer
Possible side effects Injection site pain, redness, or small swelling Headache, nausea, dizziness, or flushing Skin rashes or hives
Statistical Analysis Science and data through a recent survey in the US constantly suggests that surgery always outperforms GLP-1s, with the NIH comparison of surgical vs non-surgical revealing that patients who underwent bariatric surgery presented better weight loss progress and comorbidity resolutions
Nothing to swallow
View Study [4]"Semax, an ACTH4-10 peptide analog with high affinity for copper(II) ion and protective ability against metal induced cell toxicity" Tabbi G, Magri A, Giuffrida A, et al., 2015 Finding: Beyond its BDNF effects, this study revealed that Semax strongly binds copper ionsa metal linked to neurotoxicity in conditions like Alzheimer's